黑料网

黑料网 researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.

James F. Howard, Jr, MD, in the 黑料网 Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

Dr. Senyene Hunter, assistant professor of child neurology, was named as a 黑料网 Simmons Scholar, effective July 2022.

James F. Howard Jr., MD, professor in the 黑料网 Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

Monica Diaz, MD, MS, and Ana Felix, MBBCH, FAAN, have been elected as the 2022-2023 Vice Chairs of the American Academy of Neurology鈥檚 Global Health Section and the AB Baker Section for Neurological Education, respectively.

Robert Statts will begin his work in the interim role on March 17.

What鈥檚 new in the Department of Neurology

NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.

Dr. Robert Smith, Associate Chair for Administration, has been appointed as the Vice Dean of Gillings School of Public Health.

James F. Howard Jr., MD, professor in the 黑料网 Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.